Business Information
The group's principal activities are to manufacture and market diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes. The activities are carried out through three business segments: ophthalmic, injectable and contract services. The ophthalmic segment manufactures, markets and distributes diagnostic and therapeutic pharmaceuticals and surgical instruments and related supplies. The injectable segment manufactures, markets and distributes injectable pharmaceuticals, primarily in niche markets. The contract services segment provides contract-manufacturing services as well as product research and development services to pharmaceutical and biotechnology companies.
|
|
Name |
Title
|
Email
|
| John Kapoor | Chmn. | N/A | | Arthur Przybyl | Dir., CEO, Pres. | N/A | | Jeffrey Whitnell | CFO, Sr. VP - Finance, Sec., Treasurer | N/A | | Abu Alam | Sr. VP - New Business Development | N/A | | John Sabat | Sr. VP - National Accounting, Trade Relations | N/A |
|
|
Year |
Sales |
Net Income |
| 2005 | 44,484 | (8,609) | | 2004 | 50,708 | (3,026) | | 2003 | 45,491 | (12,325)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
